Industry News

Industry News

First Atomic-Level Images Of The Circadian CLOCK Complex

Jun 06, 2012

UT Southwestern Medical Center researchers have taken a major step toward understanding the cellular clock, mapping for the first time the atomic-level architecture of a key component of the timekeeper that governs the body's daily rhythms... Read More

Novel Way To Treat Drug-Resistant Brain Tumor Cells

Jun 06, 2012

New research from the University of Wisconsin-Madison explains why the incurable brain cancer, glioblastoma multiforme (GBM), is highly resistant to current chemotherapies. The study, from the brain-tumor research lab of Dr... Read More

Trastuzumab Emtansine, An Investigational Breast Cancer Drug, Halts Tumor Growth Better Than Standard Therapy

Jun 06, 2012

A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according to results from a Phase III clinical trial led by Kimberly Blackwell, M.D., of the Duke Cancer Institute... Read More

Trastuzumab Emtansine, An Investigational Breast Cancer Drug, Halts Tumor Growth Better Than Standard Therapy

Jun 06, 2012

A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according to results from a Phase III clinical trial led by Kimberly Blackwell, M.D., of the Duke Cancer Institute... Read More

Cancer Patients Fight Fatigue With Ginseng

Jun 06, 2012

High doses of the herb American ginseng (Panax quinquefolius) over two months reduced cancer-related fatigue in patients more effectively than a placebo, a Mayo Clinic-led study found. Sixty percent of patients studied had breast cancer. The findings were presented at the American Society of Clinical Oncology's annual meeting... Read More

Cancer Patients Fight Fatigue With Ginseng

Jun 06, 2012

High doses of the herb American ginseng (Panax quinquefolius) over two months reduced cancer-related fatigue in patients more effectively than a placebo, a Mayo Clinic-led study found. Sixty percent of patients studied had breast cancer. The findings were presented at the American Society of Clinical Oncology's annual meeting... Read More

Cymbalta Helps Treat Chemotherapy-Induced Painful Peripheral Neuropathy

Jun 05, 2012

Antidepressant Cymbalta (duloxetine) has been found to relieve the symptoms of chemotherapy-induced peripheral neuropathy, a painful tingling sensation many patients experience after undergoing chemotherapy. The researchers, from the University of Michigan School of Nursing, reported their findings at the American Society of Clinical Oncology Annual Meeting... Read More

Prostate Cancer Patients Fare Better On Continuous Hormone Therapy When Compared With Intermittent Hormone Therapy

Jun 05, 2012

Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, a cancer research cooperative group funded by the National Cancer Institute (NCI)... Read More

Prostate Cancer Patients Fare Better On Continuous Hormone Therapy When Compared With Intermittent Hormone Therapy

Jun 05, 2012

Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, a cancer research cooperative group funded by the National Cancer Institute (NCI)... Read More

New Therapy On The Horizon For ALK+ Non-Small Cell Lung Cancer

Jun 05, 2012

A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to crizotinib - the only approved ALK inhibitor... Read More

Previous Page   Next Page